NPI: 1598738064 · BESSEMER, AL 35020 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/07/2006
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 02/07/2006 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 11,974 | $215K |
| 2019 | 9,628 | $206K |
| 2020 | 14,824 | $325K |
| 2021 | 5,618 | $150K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 10,130 | 785 | $542K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 14,236 | 716 | $295K |
| J1756 | Injection, iron sucrose, 1 mg | 2,869 | 589 | $20K |
| 83970 | 639 | 507 | $14K | |
| 82108 | 390 | 300 | $5K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 9,002 | 708 | $4K |
| A4657 | Syringe, with or without needle, each | 749 | 632 | $3K |
| 82728 | 683 | 583 | $3K | |
| 83540 | 645 | 568 | $2K | |
| 84466 | 198 | 190 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 324 | 256 | $1K |
| 82607 | 144 | 110 | $1K | |
| 82746 | 152 | 118 | $838.68 | |
| 85041 | 537 | 481 | $818.09 | |
| 85048 | 538 | 481 | $761.25 | |
| 83550 | 193 | 136 | $753.28 | |
| 85046 | 105 | 102 | $274.56 | |
| 90674 | 17 | 15 | $168.78 | |
| 85045 | 59 | 55 | $159.30 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 184 | 132 | $0.00 |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 237 | 26 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 13 | 13 | $0.00 |